CN109419801A - 左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 - Google Patents
左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 Download PDFInfo
- Publication number
- CN109419801A CN109419801A CN201710790307.XA CN201710790307A CN109419801A CN 109419801 A CN109419801 A CN 109419801A CN 201710790307 A CN201710790307 A CN 201710790307A CN 109419801 A CN109419801 A CN 109419801A
- Authority
- CN
- China
- Prior art keywords
- oxiracetam
- levo
- group
- subarachnoid hemorrhage
- sah
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710790307.XA CN109419801A (zh) | 2017-09-05 | 2017-09-05 | 左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710790307.XA CN109419801A (zh) | 2017-09-05 | 2017-09-05 | 左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109419801A true CN109419801A (zh) | 2019-03-05 |
Family
ID=65514137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710790307.XA Pending CN109419801A (zh) | 2017-09-05 | 2017-09-05 | 左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109419801A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599101A (zh) * | 2013-11-08 | 2014-02-26 | 南京优科生物医药研究有限公司 | 左旋奥拉西坦在制备治疗记忆与智能障碍药物中的应用 |
-
2017
- 2017-09-05 CN CN201710790307.XA patent/CN109419801A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599101A (zh) * | 2013-11-08 | 2014-02-26 | 南京优科生物医药研究有限公司 | 左旋奥拉西坦在制备治疗记忆与智能障碍药物中的应用 |
Non-Patent Citations (3)
Title |
---|
LIANGLIANG HUANG等: "S-oxiracetam protect against ischemic stroke via alleviating blood brain barrier dysfunction in rats", 《EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES》 * |
李斌: "奥拉西坦在蛛网膜下腔出血中治疗作用及机制探讨", 《万方数据知识服务平台》 * |
杨鹏等: "氨基胍在大鼠蛛网膜下腔出血后早期脑损伤中的作用", 《医学研究生学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129396A (zh) | 淫羊藿苷在制备治疗老年痴呆的药物中的应用及产品 | |
CN102688501A (zh) | 原花青素b2磷脂复合物及其制备方法和用途 | |
CN110267658A (zh) | 用sGC刺激剂治疗CNS疾病 | |
WO2013189285A1 (zh) | 曲札茋苷在制备改善微循环障碍药物中的应用 | |
CN101273994A (zh) | 用于治疗糖尿病性视网膜病变的药物组合物及其制备方法 | |
CN109718273A (zh) | 紫苏叶提取物在预防或治疗骨性关节炎中的应用 | |
CN101530410A (zh) | 原花青素类化合物用于制备抗血管性痴呆产品的用途 | |
CN102114170B (zh) | 防治心肌缺血再灌注损伤的中药组合物及其制备方法 | |
CN102688230B (zh) | 原花青素b2的用途 | |
CN109419801A (zh) | 左旋奥拉西坦在制备预防或治疗蛛网膜下腔出血后早期脑损伤药物中的应用 | |
CN1324040C (zh) | 治疗糖尿病及糖尿病并发症的药物、制备方法及其新用途 | |
CN109758423A (zh) | 使用维生素k1脂肪乳注射液治疗凝血功能障碍的方法 | |
CN109260397A (zh) | 一种治疗眼底血管性疾病的中药组合物 | |
CN107753630A (zh) | 一种治疗失眠症的药物组合物及制备方法 | |
CN110433168B (zh) | 山茱萸新苷在制备治疗阿尔茨海默症药物中的用途 | |
CN102697766B (zh) | N-甲基胡椒乙胺或其盐在制备预防和/或治疗脑病药物中的应用 | |
CN108210879A (zh) | 一种治疗急性颅脑出血的药物组合物及其应用 | |
CN100382808C (zh) | 南葶苈子油在制备具有脑神经调节功能组合物中的应用 | |
CN102836152B (zh) | 酸浆苦素b在制备治疗和/或预防血吸虫病药物中的应用 | |
CN109806226A (zh) | 维生素k1脂肪乳注射液的用途 | |
CN101234136B (zh) | 一种治疗糖尿病视网膜病变的药物 | |
JP2006525240A (ja) | Radixnotoginshenのサポニンファミリー静脈内注射液およびその調製方法 | |
CN101647793B (zh) | 漆树酸在制备抗血管新生药物中的应用 | |
CN102648914A (zh) | 咖啡因在制备治疗老年痴呆症药物中的用途 | |
CN106619623B (zh) | 阿齐沙坦在制备帕金森病防治药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Applicant after: NANJING YOKO BIOMEDICAL R & D Ltd. Applicant after: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Applicant after: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Applicant after: NANJING LIBOWEI PHARMACEUTICAL CO.,LTD. Address before: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Applicant before: NANJING YOKO BIOMEDICAL R & D Ltd. Applicant before: NANJING YOKO BIOLOGICAL PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Applicant before: NANJING LIBOWEI PHARMACEUTICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200703 Address after: Room 310, science and technology innovation base, No.3 Hengda Road, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu Province Applicant after: Nanjing spark Pharmaceutical Technology Co.,Ltd. Address before: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Applicant before: NANJING YOKO BIOMEDICAL R & D Ltd. Applicant before: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Applicant before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Applicant before: NANJING LIBOWEI PHARMACEUTICAL Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190305 |